AIM
ITCI

Assured Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Assured Investment Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40,330
Closed -$491K – 904
2019
Q1 		$491K Buy
40,330
+20,161
+100% +$258K 0.01% 586
2018
Q4 		$230K Buy
+20,169
New +$326K 0.01% 856
2018
Q3 		– Sell
-8,176
Closed -$144K – 1319
2018
Q2 		$144K Sell
8,176
-1,182
-13% -$24K ﹤0.01% 1039
2018
Q1 		$197K Buy
+9,358
New +$182K ﹤0.01% 978

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Assured Investment Management's ITCI Position: Q2 2019 in Review

Assured Investment Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2019, closing a stake of 40,330 shares — an estimated $491K sold.

Assured Investment Management first reported a position in ITCI in Q1 2018 and held it in 4 quarters. The position peaked at $491K in Q1 2019. 126 funds tracked by Wall St. Rank hold ITCI as of Q2 2019.

  • Assured Investment Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 40,330 Intra-Cellular Therapies Inc. shares in Q2 2019, an estimated $491K.
  • Assured Investment Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2018 and held it in 4 quarters.
  • Assured Investment Management's Intra-Cellular Therapies Inc. position peaked at $491K in Q1 2019.
  • 126 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.